Before a mitral procedure, know what your records support.

Another review may help when repair, replacement, TEER, balloon treatment, or continued monitoring is being discussed and you want to understand the mechanism, timing, repairability, alternative approaches, individual risk, or whether another cardiac problem changes the plan. It should not delay urgent or time-sensitive care directed by your treating team.

Sometimes, but not every valve is durably repairable. The answer depends on the actual mechanism, leaflet and annular anatomy, calcification, tissue quality, prior procedures, and experience relevant to that lesion. The review organizes what the available imaging suggests, what remains uncertain, and why repair or replacement is being proposed without promising a repair result.

Primary mitral regurgitation begins with disease of the valve apparatus, such as prolapse or a flail leaflet. Secondary regurgitation occurs because changes in the ventricle or atrium prevent the leaflets from meeting normally. The distinction matters because the roles of repair, replacement, TEER, medical therapy, rhythm treatment, and monitoring can differ.

Yes. Mitral regurgitation is a leaking valve; mitral stenosis is a narrowed valve. Stenosis raises different questions about cause, valve area and gradients, symptoms, rhythm and clot-prevention context, anatomy, and whether monitoring, balloon commissurotomy, selected transcatheter approaches, or surgery is relevant. Repair and TEER language on this page applies to regurgitation only when supported by the record.

TEER is not a universal alternative to surgery. It may be considered for selected patients with severe symptomatic primary MR, suitable anatomy, and high surgical risk; and for selected patients with severe symptomatic secondary MR despite optimized guideline-directed heart-failure therapy and cardiac resynchronization when indicated. Ventricular status, pulmonary pressure, anatomy, excessive-gradient risk, and assessment by the treating multidisciplinary valve team also matter. A catheter procedure is not automatically better or less appropriate than surgery.

Yes, when replacement is a relevant option. The report can organize tradeoffs involving durability, lifelong anticoagulation, bleeding and clotting considerations, lifestyle, pregnancy considerations when relevant, and possible future procedures. It does not prescribe a prosthesis; the final choice belongs with you and your treating physicians.

The exact record depends on the decision. It commonly includes transthoracic echocardiogram images and reports, TEE images and report when performed or clinically relevant, catheterization or coronary assessment, clinical notes, laboratory results, medication history, rhythm information, and the proposed plan. With your authorization, the records team can help identify and request what is needed.

Specialist physicians independently review the same complete record, confer, and complete one patient-facing WHITEGLOVE Insights™ report. Expert perspectives are included in every package.

WhiteGlove Clarity is $995, Collaborative is $1,495, and Concierge is $1,995. Every package includes a written second opinion and live physician consultation. Clarity provides one specialist; Collaborative adds a multidisciplinary approach when indicated; Concierge includes a multidisciplinary team and concierge access to all physicians on that team through surgery day. These are one-time, direct-pay packages. You can purchase online or request a complimentary call.

Your report is delivered in 24 hours or less, guaranteed, after all required records and imaging are received and confirmed complete. Time spent gathering missing records is outside the 24-hour window.

No. WHITEGLOVEMD provides independent educational decision support and medical-record review. It does not diagnose, prescribe, perform procedures, provide emergency care, or replace the physicians responsible for your treatment.